Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3 - PubMed (original) (raw)

. 1990 Apr 1;144(7):2771-80.

Affiliations

PMID: 2108212

Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3

L S Schlesinger et al. J Immunol. 1990.

Abstract

We have examined the receptor-ligand interactions and the method of phagocytosis of virulent Mycobacterium tuberculosis by human monocytes. mAb against complement receptors (CR) inhibit adherence and phagocytosis of M. tuberculosis in fresh nonimmune serum. A mAb against the type 1 CR (CR1) inhibits adherence of M. tuberculosis by 40 +/- 5%, and three different mAb against the type 3 CR (CR3) each inhibit adherence by 39 +/- 5% to 47 +/- 4%. A mAb against CR1 used in combination with one of the three mAb against CR3 inhibits adherence by up to 64 +/- 7%. Most strikingly, two mAb used in combination against CR3 inhibit adherence by up to 81 +/- 2%. mAb against other monocyte surface Ag do not significantly influence adherence. In like fashion, mAb against CR but not other monocyte surface Ag inhibit adherence of preopsonized M. tuberculosis in the presence of heat-inactivated serum. By electron microscopy, monocytes ingest all M. tuberculosis that adhere in the presence of nonimmune serum; mAb against CR3 markedly inhibit ingestion. In contrast to CR, the FcR and the beta-glucan-inhibitable receptor for zymosan play little or no role in mediating M. tuberculosis adherence or ingestion. Adherence of M. tuberculosis is serum-dependent, requiring greater than or equal to 2.5% serum for optimal adherence. Heat inactivation of serum markedly reduces adherence of M. tuberculosis (75.5 +/- 7%) and preopsonization of bacteria enhances adherence by 2.9 +/- 0.4-fold. Adherence is also markedly reduced in C3- or factor B-depleted serum; repletion with C3 or factor B increases adherence by 2.1 +/- 0.4-fold and 1.86 +/- 0.05-fold, respectively. Fab anti-C3 IgG markedly inhibits monocyte adherence of preopsonized M. tuberculosis (71 +/- 1%). C component C3 is fixed to M. tuberculosis by the alternative C pathway as determined by a whole bacterial cell ELISA. Human monocytes ingest M. tuberculosis by conventional phagocytosis as viewed by electron microscopy. This study demonstrates that human monocyte CR1 and CR3 mediate phagocytosis of M. tuberculosis and C component C3 in serum is acting as the major bacterium-bound ligand.

PubMed Disclaimer

Cited by

No Strong Relationship Between Components of the Lectin Pathway of Complement and Susceptibility to Pulmonary Tuberculosis.
Chalmers JD, Matsushita M, Kilpatrick DC, Hill AT. Chalmers JD, et al. Inflammation. 2015 Aug;38(4):1731-7. doi: 10.1007/s10753-015-0150-0. Inflammation. 2015. PMID: 25761428
Reduced Mycobacterium tuberculosis association with monocytes from diabetes patients that have poor glucose control.
Gomez DI, Twahirwa M, Schlesinger LS, Restrepo BI. Gomez DI, et al. Tuberculosis (Edinb). 2013 Mar;93(2):192-7. doi: 10.1016/j.tube.2012.10.003. Epub 2012 Nov 3. Tuberculosis (Edinb). 2013. PMID: 23131496 Free PMC article.
The glycan-rich outer layer of the cell wall of Mycobacterium tuberculosis acts as an antiphagocytic capsule limiting the association of the bacterium with macrophages.
Stokes RW, Norris-Jones R, Brooks DE, Beveridge TJ, Doxsee D, Thorson LM. Stokes RW, et al. Infect Immun. 2004 Oct;72(10):5676-86. doi: 10.1128/IAI.72.10.5676-5686.2004. Infect Immun. 2004. PMID: 15385466 Free PMC article.
Mycobacteria exploit p38 signaling to affect CD1 expression and lipid antigen presentation by human dendritic cells.
Gagliardi MC, Teloni R, Giannoni F, Mariotti S, Remoli ME, Sargentini V, Videtta M, Pardini M, De Libero G, Coccia EM, Nisini R. Gagliardi MC, et al. Infect Immun. 2009 Nov;77(11):4947-52. doi: 10.1128/IAI.00607-09. Epub 2009 Aug 31. Infect Immun. 2009. PMID: 19720761 Free PMC article.
DC-SIGN induction in alveolar macrophages defines privileged target host cells for mycobacteria in patients with tuberculosis.
Tailleux L, Pham-Thi N, Bergeron-Lafaurie A, Herrmann JL, Charles P, Schwartz O, Scheinmann P, Lagrange PH, de Blic J, Tazi A, Gicquel B, Neyrolles O. Tailleux L, et al. PLoS Med. 2005 Dec;2(12):e381. doi: 10.1371/journal.pmed.0020381. Epub 2005 Nov 15. PLoS Med. 2005. PMID: 16279841 Free PMC article.

Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3 - PubMed (original) (raw)